Ophthotech reported $-49753000 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Alimera Sciences ALIM:US $ -1.97M 2.17M
Applied Genetic Technologies AGTC:US $ -17.72M 4.14M
Cytrx CYTR:US -1294610 7.73M
Insmed INSM:US $ -88316000 1.52M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Novartis NOVN:VX 2.23B 624M
Ophthotech OPHT:US $ -49.75M 15.08M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M